Adverse Events of Oncologic Immunotherapy and Their Management

• Váldodahkki: Fedricker Diane Barber (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2019-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Over the past two decades, immunotherapy has emerged as a promising treatment option for patients with cancer. However, newer versions of immunotherapy, such as checkpoint inhibitors, may be associated with unusual adverse effects (AEs) that can range in severity from mild to life-threatening. Unlik...